Details of the Drug-Related molecule(s) Interaction Atlas

General Information of Drug (ID: DMTGU6K)

Drug Name
REN-1654 Drug Info
Synonyms Antineurodegeneratives, Centaur; CPI-1160; CPI-1189; Parkinsons therapy, Centaur; REN-1189
Indication
Disease Entry ICD 11 Status REF
Cognitive impairment 6D71 Phase 2 [1]
Cross-matching ID
PubChem CID
151118
CAS Number
CAS 183619-38-7
TTD Drug ID
DMTGU6K

Molecular Interaction Atlas of This Drug

Molecular Interaction Atlas
Download the Complete Interaction Atlas for Visualization in Cytoscape

Drug Therapeutic Target (DTT)
DTT Name DTT ID UniProt ID MOA REF
JNK signaling pathway (JNK pathway) TTX1JEN NOUNIPROTAC Modulator [2]
MAPK/ERK signaling pathway (MAPK pathway) TT7KPH1 NOUNIPROTAC Modulator [2]

References

1 ClinicalTrials.gov (NCT00107055) Study of REN-1654 in Patients With Sciatica Pain. U.S. National Institutes of Health.
2 US patent application no. 2006,0270,742, Compositions and methods for the treatment of neurodegenerative diseases.